Cubist Pharma (CBST) Tops Q3 EPS by 54c

Cubist Pharma (NASDAQ: CBST) reported Q3 EPS of $0.58, $0.54 better than the analyst estimate of $0.04. Revenue for the quarter came in at $309.2 million versus the consensus estimate of $305.5 million.

For earnings history and earnings-related data on Cubist Pharma (CBST) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• HomeTrust to acquire Blue Ridge Bankshares in $448M all-stock deal
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance